ArticleBritish journal of cancer2010

Marked anti-tumour activity of the combination of YM155, a novel survivin suppressant, and platinum-based drugs.

T Iwasa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.